| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer
|
Huang, Jintuan
|
|
2018
|
22 |
2 |
p. 287-301
|
article
|
| 2 |
A randomized controlled trial of postoperative intravenous acetaminophen plus thoracic epidural analgesia vs. thoracic epidural analgesia alone after gastrectomy for gastric cancer
|
Kinoshita, Jun
|
|
2018
|
22 |
2 |
p. 392-402
|
article
|
| 3 |
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
|
Kato, Ken
|
|
2018
|
22 |
2 |
p. 344-354
|
article
|
| 4 |
CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
|
Szczepanik, Antoni
|
|
2018
|
22 |
2 |
p. 264-272
|
article
|
| 5 |
Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study
|
Uyama, Ichiro
|
|
|
22 |
2 |
p. 377-385
|
article
|
| 6 |
Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer
|
Kao, Yi-Chu
|
|
2018
|
22 |
2 |
p. 255-263
|
article
|
| 7 |
Correction to: Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma
|
Mariette, C.
|
|
2019
|
22 |
2 |
p. 421
|
article
|
| 8 |
Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer
|
Yan, Jing
|
|
2018
|
22 |
2 |
p. 302-313
|
article
|
| 9 |
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function
|
Godwin, Tanis D.
|
|
2018
|
22 |
2 |
p. 273-286
|
article
|
| 10 |
Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection
|
Kim, Tae-Se
|
|
2018
|
22 |
2 |
p. 363-368
|
article
|
| 11 |
Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples
|
Oono, Yasuhiro
|
|
2018
|
22 |
2 |
p. 335-343
|
article
|
| 12 |
Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
|
Claassen, Y. H. M.
|
|
2018
|
22 |
2 |
p. 369-376
|
article
|
| 13 |
Mutation heterogeneity between primary gastric cancers and their matched lymph node metastases
|
Lee, Han Hong
|
|
2018
|
22 |
2 |
p. 323-334
|
article
|
| 14 |
Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
|
Petrelli, Fausto
|
|
|
22 |
2 |
p. 245-254
|
article
|
| 15 |
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
|
Mondaca, Sebastian
|
|
2018
|
22 |
2 |
p. 355-362
|
article
|
| 16 |
Potential for local resection with sentinel node basin dissection for early gastric cancer based on the distribution of primary sites
|
Aoyama, Junya
|
|
2018
|
22 |
2 |
p. 386-391
|
article
|
| 17 |
Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer
|
Lin, Jian-Xian
|
|
2018
|
22 |
2 |
p. 403-412
|
article
|
| 18 |
Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study
|
Asaoka, Raito
|
|
2018
|
22 |
2 |
p. 413-420
|
article
|
| 19 |
Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis
|
Arai, Tomio
|
|
2018
|
22 |
2 |
p. 314-322
|
article
|
Journal description